TickerFacts.

Achieve Life Sciences, Inc. (ACHV): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.0K
Year ended 2025-12-31
-29.3%
5-year compound annual growth
-38.2%
10-year compound annual growth
$371.0K2009-12-31: $15.0K2010-12-31: $68.0K2011-12-31: $79.0K2012-12-31: $291.0K2013-12-31: $253.0K2014-12-31: $82.0K2015-12-31: $371.0K2016-12-31: $46.0K2018-12-31: $46.0K2019-12-31: $53.0K2020-12-31: $17.0K2023-12-31: $21.0K2025-12-31: $3.0K$3.0K
2009-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$3.0Kn/a2026-03-24, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$21.0Kn/a2026-03-24, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31$17.0K-67.9%2023-03-16, From 2020-01-01
2019-12-31$53.0K+15.2%2022-03-10, From 2019-01-01
2018-12-31$46.0Kn/a2021-03-11, From 2018-01-01
No annual figure between 2016-12-31 and 2018-12-31.
2016-12-31$46.0K-87.6%2017-02-23, From 2016-01-01
2015-12-31$371.0K+352.4%2017-02-23, From 2015-01-01
2014-12-31$82.0K-67.6%2017-02-23, From 2014-01-01
2013-12-31$253.0K-13.1%2016-03-09, From 2013-01-01
2012-12-31$291.0K+268.4%2015-03-26, From 2012-01-01
2011-12-31$79.0K+16.2%2014-03-11, From 2011-01-01
2010-12-31$68.0K+353.3%2013-03-07, From 2010-01-01
2009-12-31$15.0Kn/a2012-03-08, From 2009-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Achieve Life Sciences, Inc. (ACHV)2025-12-31$3.0Kn/a
Q/C Technologies, Inc. (QCLS)2025-12-31$1.75Mn/a
Immucell Corp (ICCC)2025-12-31$1.25M+168.5%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$3.19M+517.2%
Alpha Teknova, Inc. (TKNO)2025-12-31$1.15M+2.0%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$187.3K-12.8%
Volitionrx Ltd (VNRX)2025-12-31$89.6K-67.7%
Aspira Women's Health Inc. (AWHL)2025-12-31$16.0K-56.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$2.71M+41.4%

Compare ACHV, QCLS, ICCC, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗